Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye-Tracking device put to the test across three operating systems

NCT ID NCT07530731

Knowledge-focused Sponsor: Bulbitech Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 28, 2026 · Updated 2 times

Summary

This study checks whether BulbiCAM, a medical device that tracks eye movements, gives the same results on Windows, Ubuntu, and NixOS. Thirty-six healthy adults will complete 15 different eye tests on each system. The goal is to confirm that the operating system does not affect the accuracy of the measurements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

36 people

The number who actually took part.

Started

Apr 2026

Finished

May 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Healthy adult age 18-75 years inclusive * Willing and able to provide informed consent * Able to understand and follow instructions (Norwegian or English) * Able to complete testing procedures Exclusion Criteria: Ophthalmic: * Visual disturbance and blindness of any cause, except for corrected refractive errors * Visual acuity worse than 1.0 logMAR in the tested eye (unable to focus on test stimuli) * History of eye surgery in the last 6 months * Visible abnormalities of the eye (subconjunctival hemorrhages, inflammation, deformed pupils) * Significant eyelid ptosis that would interfere with testing * Pupils unable to respond normally to dilation/contraction due to nerve damage, mechanical damage, or medication Neurological/Medical: * Physical or psychiatric disease which may disturb the measuring procedure * Unable to tolerate testing or maintain attention for \~80 minutes with rest periods * Unable to understand and follow instructions * Photosensitive epilepsy Other: * Known alcoholic or drug dependency * Any condition that, in the investigator's judgment, would make the subject unsuitable for the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healhty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healhty

Contacts and locations

Locations

  • Bulbitech

    Trondheim, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.